IP Library › Patent Application 18584350
Patent Application
App. No. 18/584,350

IMMUNOCOMPATIBLE AMNIOTIC MEMBRANE PRODUCTS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/584,350
Abstract

Provided herein is a placental product comprising an immunocompatible amniotic membrane. Such placental products can be cryopreserved and contain viable therapeutic cells after thawing. The placental product of the present invention is useful in treating a patient with a tissue injury (e.g. wound or burn) by applying the placental product to the injury. Similar application is useful with ligament and tendon repair and for engraftment procedures such as bone engraftment.

Claims (21)

1 . A method of treating a wound, the method comprising applying to the wound a placental product comprising an amniotic membrane, a spongy layer, and a chorionic membrane to at least a portion of the wound, wherein the spongy layer is positioned between the amniotic membrane and the chorionic membrane, and wherein the placental product:

is selectively depleted of immunogenicity;

is dried, sterile, and free of viable cells; and

releases collagen, laminin, and fibronectin after being applied to the wound.

2 . The method of claim 1 , wherein the placental product does not include umbilical cord.

3 . The method of claim 1 , wherein the amniotic membrane comprises extracellular matrix native to the amniotic membrane.

4 . The method of claim 1 , wherein the chorionic membrane comprises extracellular matrix native to the chorionic membrane.

5 . The method of claim 1 , wherein the amniotic membrane and the chorionic membrane are protease-treated.

6 . The method of claim 1 , wherein the amniotic membrane and the chorionic membrane are disinfected.

7 . The method of claim 1 , wherein the placental product does not include residual blood.

8 . The method of claim 1 , wherein the placental product is less than 10 centimeters (cm)×10 cm in size.

9 . The method of claim 1 , wherein the placental product is 1 centimeter (cm)×1 cm to 5 cm×5 cm in size.

10 . The method of claim 1 , wherein the placental product is 1 centimeter (cm)×1 cm, 2 cm×2 cm, 4 cm×4 cm, 4 cm×6 cm, or 5 cm×5 cm in size.

11 . The method of claim 1 , wherein the placental product is 0.02 millimeter (mm) to 0.5 mm thick.

12 . The method of claim 1 , wherein the placental product is a single-use wound dressing.

13 . The method of claim 1 , wherein the wound is a chronic wound, an acute wound, an ulcer, a burn, a surgical wound, or a trauma wound.

14 . The method of claim 13 , wherein the ulcer is a pressure ulcer, a diabetic ulcer, or a venous ulcer.

15 . The method of claim 13 , wherein the burn is a first-degree burn, second-degree burn, a partial thickness burn, a thermal burn, or a chemical burn.

16 . The method of claim 13 , wherein the burn is not a full thickness or third-degree burn.

17 . The method of claim 13 , wherein the surgical wound is an internal wound or an external wound gained by a surgical procedure.

18 . The method of claim 13 , wherein the trauma wound is a laceration, scrape, incision, or puncture.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 26, 2024
From: TOM, SAMSON; DANILKOVITCH, ALLA; YOO, DANA; JANSEN, TIMOTHY; KUANG, JIN-QIANG; MARCONI, JENNIFER MICHELLE
To: OSIRIS THERAPEUTICS, INC.
Reel/Frame 066904/0958 →